HIV/AIDS Therapy

New grant awarded to develop anti-HIV drugs

Published in AIDS Weekly, June 23rd, 2003

PTC Therapeutics has been awarded a Phase II Small Business Technology Transfer (STTR) grant from the National Institute of Allergy and Infectious Disease of the National Institutes of Health (NIAID/NIH) to develop a virus-cell-based assay using HIV-1 vector systems for the discovery of novel drugs with anti-HIV activity.

According to a PTC statement, the worldwide population of patients infected with this virus and developing AIDS is still increasing significantly. Although drugs that inhibit the activity of certain HIV enzymes, and thus inhibit HIV replication, have been identified and utilized successfully to treat AIDS (e.g., inhibitors of the viral reverse...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2003-06-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry